We are live on ! Find out more
LD

Lipe & Dalton Portfolio holdings

AUM $215M
1-Year Est. Return 39.53%
This Fund
S&P 500
This Quarter Est. Return
+5.94%
1 Year Est. Return
+39.53%
3 Year Est. Return
+89.64%
5 Year Est. Return
+111.74%
10 Year Est. Return
+427.59%
AUM
$194M
AUM Growth
+$9.69M
Cap. Flow
+$1.08M
Cap. Flow %
0.56%
Top 10 Hldgs %
37.36%
Holding
111
New
7
Increased
29
Reduced
23
Closed
5

Top Sells

Rank Stock Value
1
SYF icon
Synchrony
SYF
+$2.09M
2
PRU icon
Prudential Financial
PRU
+$1.21M
3
MRNA icon
Moderna
MRNA
+$390K
4
LDOS icon
Leidos
LDOS
+$347K
5
DE icon
Deere & Co
DE
+$192K

Sector Composition

Rank Sector Weight
1 Technology 21.81%
2 Industrials 17.11%
3 Healthcare 16.97%
4 Financials 14.32%
5 Consumer Discretionary 7.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NUE icon
101
Nucor
NUE
$56.4B
$20K 0.01%
100
IBM icon
102
IBM
IBM
$202B
$19K 0.01%
+100
New +$18.2K
UNP icon
103
Union Pacific
UNP
$183B
$18K 0.01%
75
ROP icon
104
Roper Technologies
ROP
$36.3B
$14K 0.01%
25
BNS icon
105
Scotiabank
BNS
$106B
$6K ﹤0.01%
125
ADVM
106
DELISTED
Adverum Biotechnologies
ADVM
-1,500
Closed -$11K
CMCSA icon
107
Comcast
CMCSA
$79.1B
-834
Closed -$37K
FCX icon
108
Freeport-McMoran
FCX
$90B
-4,000
Closed -$170K
PRU icon
109
Prudential Financial
PRU
$41.7B
-11,652
Closed -$1.21M
SYF icon
110
Synchrony
SYF
$23.7B
-54,827
Closed -$2.09M

Similar funds

Lipe & Dalton's Q1 2024 Portfolio in Review

As of Q1 2024, Lipe & Dalton held 111 positions worth $194M, up 5.3% from $184M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Lipe & Dalton's Q1 2024 filing shows 7 new, 29 increased, 23 reduced and 5 closed positions. Its largest new stake was BorgWarner: 70,745 shares worth $2.46M. The largest sale was Synchrony, an estimated $2.09M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Industrials and Healthcare.

  • Lipe & Dalton's largest Q1 2024 buy was BorgWarner: 70,745 shares worth $2.46M.
  • Lipe & Dalton added most to Boeing in Q1 2024, an estimated $454K increase.
  • Lipe & Dalton's biggest Q1 2024 reduction was Moderna, cutting an estimated $390K.
  • Lipe & Dalton fully exited Synchrony in Q1 2024, selling an estimated $2.09M.
  • Lipe & Dalton's ten largest holdings make up 37% of its $194M portfolio in Q1 2024.
  • Lipe & Dalton opened 7 new positions and closed 5 in Q1 2024.
  • Lipe & Dalton's portfolio value rose 5.3% quarter-over-quarter to $194M.

Based on Lipe & Dalton's 13F filing for Q1 2024, filed 7 May 2024.